Activity of a synthetic hexadecasaccharide (SanOrg123781A) in a pig model of arterial thrombosis.

about

Tissue factor, blood coagulation, and beyond: an overview.Heparin Mimetics: Their Therapeutic Potential.

P2860

Q35222618-2CE49C78-BC29-4F4B-8FF4-72EE0FB68CAE Q47159791-6CD4B1EA-6A19-4104-8107-CF43CA349D33

P2860

Activity of a synthetic hexadecasaccharide (SanOrg123781A) in a pig model of arterial thrombosis.

Item

http://www.wikidata.org/entity/Q44893876

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Activity of a synthetic hexade ...... model of arterial thrombosis.

@en

Activity of a synthetic hexadecasaccharide

@nl

type

Item

label

Activity of a synthetic hexade ...... model of arterial thrombosis.

@en

Activity of a synthetic hexadecasaccharide

@nl

prefLabel

Activity of a synthetic hexade ...... model of arterial thrombosis.

@en

Activity of a synthetic hexadecasaccharide

@nl

P1476

Activity of a synthetic hexade ...... model of arterial thrombosis.

@en

P2093

Bal dit Sollier C

http://www.w3.org/2001/XMLSchema#string

Berge N

http://www.w3.org/2001/XMLSchema#string

Bonneau M

http://www.w3.org/2001/XMLSchema#string

Drouet L

http://www.w3.org/2001/XMLSchema#string

Herault JP

http://www.w3.org/2001/XMLSchema#string

Herbert JM

http://www.w3.org/2001/XMLSchema#string

Kang C

http://www.w3.org/2001/XMLSchema#string

P2860

Heparin-induced thrombocytopenia: a ten-year retrospective

Synthesis of thrombin-inhibiting heparin mimetics without side effects.

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety.

Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention.

Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparin.

Are the pharmacokinetic parameters of low molecular weight heparins predictive of their clinical efficacy?

Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.

The inhibition of blood coagulation by heparins of different molecular weight is caused by a common functional motif--the C-domain.

Influence of the duration of fondaparinux (Arixtra) prophylaxis in preventing venous thromboembolism following major orthopedic surgery.

Optimal antagonism of GPIIb/IIIa favors platelet adhesion by inhibiting thrombus growth. An ex vivo capillary perfusion chamber study in the guinea pig.

P304

925-930

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1538-7836.2004.00719.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8566100

http://www.w3.org/2001/XMLSchema#string

P698

15140128

http://www.w3.org/2001/XMLSchema#string

P921

thrombosis

Activity of a synthetic hexadecasaccharide (SanOrg123781A) in a pig model of arterial thrombosis.

about

P2860

P2860

Activity of a synthetic hexadecasaccharide (SanOrg123781A) in a pig model of arterial thrombosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921